Procaps Group, S.A Pre-Tax Profit Margin 2020-2023 | PROCF

Procaps Group, S.A pre-tax profit margin from 2020 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Procaps Group, S.A Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2023-09-30 $0.41B $0.07B 16.46%
2023-06-30 $0.41B $0.09B 21.48%
2023-03-31 $0.41B $0.04B 9.83%
2022-12-31 $0.41B $0.05B 12.96%
2022-09-30 $0.44B $0.08B 17.93%
2022-06-30 $0.43B $-0.06B -13.66%
2022-03-31 $0.42B $-0.05B -11.93%
2021-12-31 $0.41B $-0.09B -21.22%
2021-09-30 $0.54B $-0.13B -23.93%
2021-06-30 $0.51B $-0.02B -4.54%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.125B $0.410B
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Stock Name Country Market Cap PE Ratio
NextEra Energy Partners, LP (XIFR) United States $0.828B 4.49